Clovis Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference

JPMorgan Healthcare Conference 2013

BOULDER, Colo.--()--Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, Chief Executive Officer and President of Clovis will present at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2012 at 9:00 AM Pacific Time. The conference will be held at the Westin St. Francis Hotel in San Francisco, CA.

A live webcast of the presentation can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK.

Contacts

Clovis Oncology
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com

Release Summary

Clovis CEO to present at JP Morgan Healthcare Conference

Sharing

Contacts

Clovis Oncology
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com